Beranda › Kanker Prostat › California

Uji klinis Kanker Prostat di California

156 studi untuk Kanker Prostat mencari peserta di lokasi di California.

Kota di California

Teks studi resmi (Bahasa Inggris)

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

University of San Diego Moores Cancer Center, La Jolla
UCLA Jonsson Comprehensive Cancer Center, Los Angeles
USC Norris Comprehensive Cancer Center, Los Angeles

Menerima pesertaFase 1/2

Usia 12 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT04585750

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

Kaiser Permanente Dublin, Dublin
Kaiser Permanente-Fremont, Fremont
Kaiser Permanente Fresno Orchard Plaza, Fresno
dan 18 lainnya

Menerima pesertaFase 3

Usia 18 ke atas · Pria · Diperbarui 2 Okt 2026 · NCT06931340

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
City of Hope at Irvine Lennar, Irvine
dan 5 lainnya

Menerima pesertaFase 3

Usia 18 ke atas · Pria · Diperbarui 2 Okt 2026 · NCT07200830

Distance-Based Exercise to Preserve Function and Prevent Disability

Kaiser Permanente Dublin, Dublin
Kaiser Permanente-Fremont, Fremont
Kaiser Permanente Fresno Orchard Plaza, Fresno
dan 10 lainnya

Menerima peserta

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07059884

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

City of Hope National Medical Center, Duarte
University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla
UCLA Department of Medicine-Hematology/Oncology, Los Angeles

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06465069

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
PCR Oncology, Arroyo Grande
AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
dan 20 lainnya

Menerima pesertaStudi observasionalSukarelawan sehat diterima

Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

Enloe Medical Center, Chico
UC San Diego Health System - Encinitas, Encinitas
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
dan 4 lainnya

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06632977

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

City of Hope, Duarte

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06172478

Study of AR Suppression With Carotuximab in Metastatic, Castration-Resistant Prostate Canc

City of Hope, Duarte
Cedars-Sinai Medical Center, Los Angeles

Menerima pesertaFase 2

Usia 18 ke atas · Pria · Diperbarui 30 Sep 2026 · NCT05534646

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Keck Medicine of USC Koreatown, Los Angeles
Los Angeles General Medical Center, Los Angeles
USC / Norris Comprehensive Cancer Center, Los Angeles
dan 1 lainnya

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT03866382

Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence

University of California San Diego Health, San Diego

Menerima pesertaFase 4

Usia 18 ke atas · Pria · Diperbarui 29 Sep 2026 · NCT07569926

An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer.

UCLA / Jonsson Comprehensive Cancer Center, Los Angeles

Menerima pesertaFase 2

Usia 18 hingga 90 · Pria · Diperbarui 29 Sep 2026 · NCT07185165

Precision-Based Genomics in Prostate Cancer

University of California San Diego, La Jolla
University of California San Francisco, San Francisco

Menerima pesertaStudi observasional

Usia 18 hingga 120 · Pria · Diperbarui 28 Sep 2026 · NCT04706663

Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix

Om Research, San Diego

Menerima pesertaStudi observasional

Usia 40 hingga 75 · Pria · Diperbarui 28 Sep 2026 · NCT07543757

DESTINY-PANTUMOUR04

Research Site, San Diego

Menerima pesertaStudi observasional

Usia 18 hingga 130 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07124000

Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

Research Site, Los Angeles

Menerima pesertaFase 1/2

Usia 18 hingga 130 · Pria · Diperbarui 25 Sep 2026 · NCT07181161

Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer

University of California San Diego, Moores Cancer Center, La Jolla

Menerima pesertaFase 1

Usia 18 ke atas · Pria · Diperbarui 25 Sep 2026 · NCT06801236

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

CHAO Family Comprehensive Cancer Center and Ambulatory Care ( Site 0120), Irvine
UCLA Hematology/Oncology - Santa Monica ( Site 0044), Los Angeles
University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 0040), Orange
dan 4 lainnya

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06136650

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

UCLA Hematology/Oncology - Alhambra, Alhambra
UCLA Hematology/Oncology - Atascadero, Atascadero
Cedars-Sinai Cancer Beverly Hills (drug treatment and dispensing location), Beverly Hills
dan 20 lainnya

Menerima pesertaFase 3

Usia 18 ke atas · Pria · Diperbarui 24 Sep 2026 · NCT07028853

A Study in Patients With Metastatic Castration-Resistant Prostate Cancer

START Los Angeles, Los Angeles

Menerima pesertaFase 1

Usia 18 ke atas · Pria · Diperbarui 24 Sep 2026 · NCT07719361

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

VA Greater LA Healthcare System, Los Angeles
VA Palo Alto Health Care System, Palo Alto
Stanford University Medical Center, Palo Alto
dan 2 lainnya

Menerima pesertaFase 2/3

Usia 18 hingga 100 · Pria · Diperbarui 22 Sep 2026 · NCT06780670

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

City of Hope, Duarte
University of California, Los Angeles (UCLA), Santa Monica
Stanford University Medical Center, Stanford

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07114601

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

City of Hope National Medical Center, Duarte
City of Hope Orange County Lennar Foundation Cancer Center, Duarte
Providence Saint Jude Medical Center, Fullerton
dan 3 lainnya

Menerima pesertaFase 3

Usia 18 ke atas · Pria · Diperbarui 22 Sep 2026 · NCT07213674

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

Univ Cali Irvine ALS Neuromuscular, Orange
Stanford University Medical Center, Palo Alto
Sansum Clinic, Santa Barbara

Menerima pesertaFase 3

Usia 18 hingga 100 · Pria · Diperbarui 22 Sep 2026 · NCT06855277

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

Research Site, La Jolla
Research Site, La Jolla
Research Site, Los Angeles
dan 2 lainnya

Menerima pesertaFase 3

Usia 18 ke atas · Pria · Diperbarui 18 Sep 2026 · NCT06952803

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

VA Greater Los Angeles Healthcare System, West Los Angeles, CA, West Los Angeles

Menerima pesertaFase 2

Usia 18 ke atas · Pria · Diperbarui 17 Sep 2026 · NCT04038502

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

City of Hope Comprehensive Cancer Center ( Site 0049), Duarte
City of Hope Lennar Foundation Cancer Center ( Site 0059), Irvine
Moores Cancer Center ( Site 0010), La Jolla
dan 5 lainnya

Menerima pesertaFase 3

Usia 18 ke atas · Pria · Diperbarui 17 Sep 2026 · NCT06925737

First-Time-in-Human Study of GSK5471713 in Adults With mCRPC

GSK Investigational Site, La Jolla

Menerima pesertaFase 1/2

Usia 18 ke atas · Pria · Diperbarui 16 Sep 2026 · NCT07332455

A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer

Hoag Memorial Hospital Presbyterian, Irvine

Menerima pesertaFase 1

Usia 18 ke atas · Pria · Diperbarui 15 Sep 2026 · NCT07581184

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

USNC, Mountain View
Tri Valley Urology, Murrieta
University of California San Francisco, San Francisco

Menerima peserta

Usia 18 ke atas · Pria · Diperbarui 14 Sep 2026 · NCT06511141

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

Urology Group of Southern California, Los Angeles
Greater Los Angeles VA Medical Center, Los Angeles
UC Irvine Health, Orange
dan 1 lainnya

Menerima pesertaFase 3

Usia 18 ke atas · Pria · Diperbarui 11 Sep 2026 · NCT06056830

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Kaiser Permanente-Deer Valley Medical Center, Antioch
Tower Cancer Research Foundation, Beverly Hills
Kaiser Permanente Dublin, Dublin
dan 34 lainnya

Menerima pesertaFase 3

Usia 18 ke atas · Pria · Diperbarui 10 Sep 2026 · NCT05946213

Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

UCI Health Chao Family Comprehensive Cancer Center, Orange
Investigational Site Number: 403, Palo Alto

Menerima pesertaFase 1

Usia 18 ke atas · Pria · Diperbarui 10 Sep 2026 · NCT05997615

Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer

University of California, San Francisco, San Francisco

Menerima pesertaFase 2

Usia 18 ke atas · Pria · Diperbarui 10 Sep 2026 · NCT05766371

Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate Cancer

Duarte Cancer Center, Duarte
City of Hope Orange County Lennar Foundation Cancer Center, Irvine

Menerima peserta

Usia 18 ke atas · Pria · Diperbarui 9 Sep 2026 · NCT05804318

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

USC/Norris Comprehensive Cancer Center, Los Angeles

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT06440005

Longitudinal Advanced Prostate Cancer Cohort (LAPCC)

Los Angeles General Medical Center, Los Angeles
USC / Norris Comprehensive Cancer Center, Los Angeles

Menerima pesertaStudi observasional

Usia 18 ke atas · Pria · Diperbarui 8 Sep 2026 · NCT06067295

Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer

UC San Diego Moores Cancer Center, La Jolla

Menerima pesertaFase 1

Usia 18 ke atas · Pria · Diperbarui 3 Sep 2026 · NCT07545811

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

Sharp HealthCare - Sharp Memorial Hospital, San Diego

Menerima pesertaFase 2

Usia 18 ke atas · Pria · Diperbarui 3 Sep 2026 · NCT07005154

Prostate Active Surveillance Study

Veterans Affairs San Francisco Health Care System, San Francisco
University of California, San Francisco, San Francisco
Stanford University, Stanford

Menerima pesertaStudi observasional

Usia 21 ke atas · Pria · Diperbarui 2 Sep 2026 · NCT00756665

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.